EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSLBEG00000010285
Gene Symbol: DHCR24
3 Cross references
207 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSLBEG00000012351
Gene Symbol: LOC109992389
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSLBEG00000012357
Gene Symbol: LOC110001694
4 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSLBEG00000028766
Gene Symbol: LOC109979650
4 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSLBEG00000025965
Gene Symbol: LOC109995013
3 Cross references
226 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSLBEG00000005775
Gene Symbol: LOC109990045
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6-Like

Ensembl ID : ENSLBEG00000009315
Gene Symbol: LOC110006134
3 Cross references
211 Possible Orthologues:

26s Proteasome Regulatory Subunit 6b-Like

Ensembl ID : ENSLBEG00000001400
Gene Symbol: LOC109977436
3 Cross references
196 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSLBEG00000003504
Gene Symbol: HMGCR
3 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSLBEG00000028020
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSLBEG00000006255
Gene Symbol: LOC109981992
3 Cross references
207 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSLBEG00000017437
Gene Symbol: LOC110000112
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).